First Western Ship Transits Strait of Hormuz Since Iran War Began 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Britain Courts Anthropic Amid US Defense Department Dispute 
Houston, TX, Sept. 14, 2017 -- Heart patients, family members, caregivers and medical professionals from across the country are expected to participate in the Mended Little Hearts CHD Symposium September 22-23, 2017 in Houston, Texas. The two-day event will be held at Texas Children’s Hospital and includes an ‘Out of this World’ reception, a tour of Texas Children’s Hospital Heart Center and entrance to the Houston Astros game Saturday evening.
|
||||||
The conference is open to anyone affected by congenital heart disease and will feature multiple speakers, including panels on supporting teens and families during their transition to adult CHD care, innovations in CHD treatment, collaborative innovations that improve lives, caring for the needs of the child and family, and more.
"I am truly excited that we are bringing our CHD Symposium to Houston,” said Donnette Smith, President of Mended Hearts and Mended Little Hearts. “Not only will participants hear about the latest innovations in CHD research and treatment, but they’ll learn how collaboration between medical staff, patients and caregivers can help improve the lives of those affected by CHD. They’ll also have the unique opportunity to network with other patients and families who have gone through what they’ve experienced.”
To register for the MLH CHD Symposium, please go to:
https://events.r20.constantcontact.com/register/eventReg?oeidk=a07eee1g3j58e69d9a0&oseq=&c=&ch=
Mended Little Hearts gratefully acknowledges the support of our Symposium sponsors: Edwards Lifesciences, Abbott, Prolacta, Syncardia, and Medtronic.
About Mended Little Hearts
Mended Little Hearts plays a significant role in the lives of families with children diagnosed with congenital heart defects. Through its local support group meetings, health education to communities, hospital support programs, disease awareness activities, and advocacy on issues that affect our families, Mended Little Hearts provides hope, help and healing so families can be families and kids can be kids. Mended Little Hearts is a program of The Mended Hearts Inc., a non-profit, volunteer-based organization providing hope, help and healing to heart patients and their families since 1951.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/67752cc8-cf16-42d3-b3cc-f4d6ec61163a
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/edf18634-9cba-4314-903b-5c85472e03a7
Mandy Sandkuhler Mended Little Hearts 4698883400 [email protected]
